EDT — Spectral Medical Cashflow Statement
0.000.00%
Last trade - 00:00- CA$410.79m
- CA$431.84m
- CA$2.44m
Annual cashflow statement for Spectral Medical, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -8.79 | -11.3 | -15.7 | -15.4 | -47.7 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 1.55 | 0.391 | 5.13 | 5.32 | 38.1 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.76 | 0.659 | -0.406 | 1.01 | -0.189 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -8.7 | -9.93 | -10.7 | -8.82 | -9.52 |
| Capital Expenditures | -0.483 | -0.033 | -0.185 | -0.027 | -0.195 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0.158 | 0 | — | — | — |
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | -0.325 | -0.033 | -0.185 | -0.027 | -0.195 |
| Financing Cash Flow Items | -1.13 | -1.33 | 1.51 | -2.02 | -2.11 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 12.2 | 9.48 | 5.44 | 8.88 | 10.8 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 3.08 | -0.476 | -5.46 | 0.036 | 1.08 |